The MidCap index almost mirrored Sensex and Nifty while the SmallCap underperformed, rising 0.6%. Fifteen of the 19 sectoral indices compiled by BSE Ltd. rose with Auto index adding 2.5%.
The market breadth is skewed in the favour of bulls. About 1,703 stocks rose, 1,456 fell an d 158 remained unchanged.
Shares of Aurobindo Pharma are on course to extend gains for the fourth day.
The company's subsidiary Eugia Pharma received final approval from U.S. FDA to manufacture and market Triamcinolone Acetonide Injectable Suspension 200 mg/5 mL, 400 mg/10 mL, multiple-dose vials.
The drug is therapeutically equivalent to RLD, Kenalog-40 Injectable Suspension, 40 mg/mL of Bristol-Myers Squibb.
The drug, which is being launched this month, has an estimated market size of $73 million for twelve months ending May 2022, according to IQVIA.
The drug is a glucocorticoid cortisteroid (anti-inflammation) and indicated for treatment of intramuscular and intra-articular inflammation.
The broader indices almost mirrored their larger peers. Sixteen of the 19 sectoral indices compiled by BSE Ltd. advanced with Auto and Bankex indices rising over 0.75%. On the flipside, the Metal gauge shed nearly 2%.
The market breadth is skewed in the favour of bulls. About 1,506 stocks rose, 660 fell and 100 remained unchanged.
ONGC/Oil India/RIL: Crude oil rebounded above $100/barrel as banks including Goldman Sachs said a plunge driven by fears a recession will hurt demand was overdone.
IOCL/BPCL/HPCL: Ethanol used for blending with petrol to the extent of 15% will be exempted from excise duty. Diesel blending will also be exempt up to 20%.
Marico: Marico expects “mid-single-digit” decline in domestic volume for the quarter ended June 30 as steep price hikes led to downtrading across two of its largest brands.
Biocon: The company has received EU GMP certification for its new monoclonal antibodies drug substance manufacturing facility in Bengaluru, following a GMP inspection in April 2022.
Bajaj Finance: Assets under management rose 3.55% month-on-month to Rs 2.04 lakh crore in the quarter ended June, even as net liquidity surplus was Rs 11,550 crore.
South Indian Bank: Advances grew 11% year-on-year and 4.8% sequentially to Rs. 62,095 crore. Deposits rose 4% over a year ago but fell 1% on a quarterly basis. The lender's CASA ratio stood at 34% in Q1 FY23 compared to 33% in Q4 FY22 and 30% in Q1 FY22.
J Kumar Infraprojects: The company has received letter of acceptance from BMC for building Sewer Tunnel-Phase I from Don Bosco to New Malad IP. The project is worth Rs 571.01 crore, and the company has 60% stake in the JV which comes to Rs 342.60 crore.
Garden Reach Shipbuilders: Inks pact with West Bengal to build an electric ferry.